Abstract: The present invention relates to the use of a TLR9 agonist and/or a TLR4 antagonist and/or a NOD2 agonist for treatment or prevention of disorders involving TLR4 activation, such as systemic sepsis and necrotizing enterocolitis.
Type:
Application
Filed:
August 26, 2013
Publication date:
October 20, 2016
Applicant:
University of Pittsburgh - of the Commonwealth System of Highter Education
Abstract: The present invention relates to the use of a TLR9 agonist and/or a TLR4 antagonist and/or a NOD2 agonist for treatment or prevention of disorders involving TLR4 activation, such as systemic sepsis and necrotizing enterocolitis.
Type:
Application
Filed:
August 26, 2013
Publication date:
February 26, 2015
Applicant:
University of Pittsburgh - of the Commonwealth System of Highter Education